Tolterodine - A new bladder-selective antimuscarinic agent

European Journal of Pharmacology

Volumn 327, Issue 2-3, 1997, Pages 195-207

  Nilvebrant, Lisbeth ^a   Andersson, Karl Erik ^b   Gillberg, Per Göran ^a   Stahl, Matthias ^b   Sparf, Bengt ^a  

^a PFIZER INC   (United States)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cat; Guinea pig; Human; Muscarinic receptor antogonist; Muscarinic receptor subtype; Salivation; Urinary bladder contraction

Indexed keywords

ACETYLCHOLINE; ATROPINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NEW DRUG; OXYBUTYNIN; RECEPTOR SUBTYPE; TOLTERODINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BLADDER CONTRACTION; CAT; CHO CELL; DRUG EFFECT; DRUG RECEPTOR BINDING; GUINEA PIG; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; SALIVATION; URGE INCONTINENCE;

EID: 0030997354     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)89661-6     Document Type: Article

References (44)

1. 3H-acetylcholine secretion in the guinea pig urinary bladder in vitro. J. Pharmacol. Exp. Ther. 274:1995;458-468.
2. Andersson K.-E. Current concepts in the treatment of disorders of micturition. Drugs. 35:1988;477-494.
3. Andersson K.-E. The pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol. Rev. 45:1993;253-308.
4. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein using the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
5. Buckley N.J., Bonner T.I., Buckley C.M., Brann M.R. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol. Pharmacol. 35:1989;469-476.
6. Caulfield M.P. Muscarinic receptor - characterization, coupling and function. Pharmacol. Ther. 58:1993;319-379.
7. Chen Q., Yu P., De Petris G., Biancani P., Behar J. Distinct muscarinic receptors and signal transduction pathways in gallbladder muscle. J. Pharmacol. Exp. Ther. 273:1995;650-655.
8. Darke A.C., Smaje L.H. Dependence of functional vasodilatation in the cat submaxillary gland upon stimulation frequency. J. Physiol. 226:1972;191-203.
9. De Groat, W.C., Booth, A.M., Yoshimura, N., 1993. Neurophysiology of micturition and its modification in animal models of human disease. In: Maggi, C.A. (Ed.), Nervous Control of the Urogenital System. Harwood Academic Publishers, Amsterdam, pp. 227-290.
10. Doods H.N., Willim K.D., Boddeke H.W.G.M., Entzeroth M. Characterization of muscarinic receptors in guinea pig uterus. Eur. J. Pharmacol. 250:1993;223-230.
11. Eglen R.M., Watson N. Selective muscarinic receptor agonists and antagonists. Pharmacol. Toxicol. 78:1996;59-68.
12. Eglen R.M., Michel A.D., Whiting R.L. Characterization of the muscarinic receptor subtype mediating contraction of the guinea pig uterus. Br. J. Pharmacol. 96:1989;497-499.
13. Eglen R.M., Reddy H., Watson N., Challis R.A.J. Muscarinic acetylcholine receptors in smooth muscle. Trends Pharmacol. Sci. 15:1994;114-119.
14. Flood, H.D., Somogyi, G.T., Bellinger, M.F., Groat, W.C., 1994. Muscarinic facilitation of acetylcholine release in the human bladder: a mechanism for enhancement of micturition contractions. In: Proceedings of the 24th Annual Meeting of the International Continence Society; Aug. 31-Sept. 2, 1994, Prague. p. 62.
15. Giraldo E., Vigano M.A., Hammer R., Ladinsky H. Characterization of muscarinic receptors in guinea pig ileum longitudinal smooth muscle. Mol. Pharmacol. 33:1987;617-625.
16. 2 muscarinic receptors in rat intestinal smooth muscle. J. Pharmacol. Exp. Ther. 263:1992;221-225.
17. Hulme E.C., Birdsall N.J.M., Buckley N.J. Muscarinic receptor subtypes. Annu. Rev. Pharmacol. Toxicol. 30:1990;633-673.
18. Jacobs S., Chang K.-J., Cuatrecasas P. Estimation of hormone receptor affinity by competitive displacement of labelled ligand. Biochem. Biophys. Res. Commun. 66:1975;687-692.
19. Khadra M.H., Satchell P.M., Vaughan C.W. Sympathetic nervous system effects on feline bladder wall compliance throughout continence. Acta Physiol. Scand. 155:1995;31-39.
20. Kondo S., Morita T., Tashima Y. Muscarinic cholinergic receptor subtypes in human detrusor muscle studied by labeled and nonlabeled pirenzepine, AFDX-116 and 4DAMP. Urol. Int. 54:1995;150-153.
21. 4 binding sites in rabbit lung, chicken heart and NG108-15 cells. Mol. Pharmacol. 38:1990;805-815.
22. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
23. Maeda A., Kubo T., Mishima M., Numa S. Tissue distribution of mRNAs encoding muscarinic acetylcholine receptor subtypes. FEBS Lett. 239:1988;339-342.
24. 2 muscarinic receptors in longitudinal ileal smooth muscle membranes. Eur. J. Pharmacol. 145:1988;305-311.
25. Nilvebrant L. On the muscarinic receptors in the urinary bladder and the putative subclassification of muscarinic receptors. Acta Pharmacol. Toxicol. 59(Suppl. 1):1986;1-45.
26. Nilvebrant L., Sparf B. Muscarinic receptor binding in the guinea pig parotid gland. Different affinities of some anticholinergic drugs between the parotid gland and ileum. Scand. J. Gastroenterol. 17(Suppl. 72):1982;69-77.
27. Nilvebrant L., Sparf B. Differences between binding affinities of some antimuscarinic drugs in the parotid gland and those in the urinary bladder and ileum. Acta Pharmacol. Toxicol. 53:1983;304-313.
28. Nilvebrant L., Sparf B. Muscarinic receptor binding in the guinea pig urinary bladder. Acta Pharmacol. Toxicol. 52:1983;30-38.
29. Nilvebrant L., Sparf B. Dicyclomine, benzhexol and oxybutynin distinguish between subclasses of muscarinic binding sites. Eur. J. Pharmacol. 123:1986;133-143.
30. Nilvebrant L., Sparf B. Receptor binding profiles of some selective muscarinic antagonists. Eur. J. Pharmacol. 151:1988;83-96.
31. Nilvebrant L., Andersson K.-E., Mattiasson A. Characterization of the muscarinic cholinoceptors in the human detrusor. J. Urol. 134:1985;418-423.
32. 3 receptors and in vivo effects on urinary bladder contraction, mydriasis and salivary secretion in guinea pigs. J. Pharmacol. Exp. Ther. 256:1991;562-567.
33. 2 receptors and β-adrenoceptor subtypes in guinea pig isolated ileum. Br. J. Pharmacol. 114:1995;49-56.
34. x and competitive drug antagonism. Br. J. Pharmacol. Chemother. 4:1949;277-280.
35. Somogyi G.T., De Groat W.C. Evidence for inhibitory nicotinic and facilitatory muscarinic receptors in cholinergic nerve terminals of the rat urinary bladder. J. Auton. Nerv. Syst. 37:1992;89-98.
36. 1 muscarinic receptor-mediated facilitation of acetylcholine release in the rat urinary bladder. J. Physiol. 480:1994;81-89.
37. 2 muscarinic receptor in smooth muscle of guinea pig ileum. Mol. Pharmacol. 44:1993;102-110.
38. 3H]acetylcholine release in the rabbit urinary bladder. Eur. J. Pharmacol. 281:1995;1-8.
39. Wammack R., Weihe E., Dienes H.-P., Hohenfeller R. Di meurogene Blase in vitro. Akt. Urol. 26:1995;16-18.
40. Wang P., Luthin G.R., Ruggieri M.R. Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins. J. Pharmacol. Exp. Ther. 273:1995;959-966.
41. Wein, A.J., Longhurst, P.A., Levin, R.M., 1994. Pharmacologic treatment of voiding dysfunction. In: Munday, R.A., Stephenson, T.P., Wein, A.J. (Eds.), Urodynamics: Principles, Practice and Application, 2nd ed. Churchill Livingstone, New York, NY, pp. 43-70.
42. Yamaguchi O., Shishido K., Tamura K., Ogawa T., Fujimura T. Evaluation of mRNA encoding muscarinic receptor subtypes in human detrusor muscle. Neurourol. Urodyn. 13:1994;464-465.
43. Yarker Y.E., Goa K.L., Fitton A. Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in detrusor instability. Drugs Aging. 6:1995;243-262.
44. Zhang L., Buxton I.L.O. Muscarinic receptors in canine colonic circular smooth muscle. II. Signal transduction pathways Mol. Pharmacol. 40:1991;952-959.